The simultaneous high expression of Vα24, IFN-γ and FoxP3 characterizes the liver of children with type I autoimmune hepatitis

Clinical Immunology

Volumn 137, Issue 3, 2010, Pages 396-405

  Ferreyra Solari, Nazarena E ^a   Galoppo, Cristina ^b   Cuarterolo, Miriam ^c   Goñi, Javier ^c   Fernández Salazar, Luis ^d   Arranz, Luis E ^e   Garrote, Jose A ^d,e   Cherñavsky, Alejandra C ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^b HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^c HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^d HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^e UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Regulatory subpopulations; Th1 Th17 cytokines; Type I autoimmune hepatitis

Indexed keywords

AMINOTRANSFERASE; AZATHIOPRINE; GAMMA INTERFERON; INTERLEUKIN 12P40; INTERLEUKIN 21; INTERLEUKIN 27; PREDNISOLONE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; TRANSCRIPTION FACTOR FOXP3;

ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CHILD; CLINICAL ARTICLE; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION; HUMAN; INNATE IMMUNITY; LIVER INJURY; MALE; MEDIATOR; PRIORITY JOURNAL; REMISSION;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HEPATITIS, AUTOIMMUNE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKINS; LIVER; MALE; POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL; RNA, MESSENGER; TRANSAMINASES;

EID: 78149266872     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.08.013     Document Type: Article

References (53)

1. Czaja A.J. Natural history, clinical features, and treatment of autoimmune hepatitis. Semin. Liver Dis. 1984, 4:1-12.
2. Johnson P.J., McFarlane I.G. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993, 18:998-1005.
3. Mackay I.R. Immunological aspects of chronic active hepatitis. Hepatology 1983, 3:724-728.
4. Klugewitz K., Adams D.H., Emoto M., Eulenburg K., Hamann A. The composition of intrahepatic lymphocytes: shaped by selective recruitment?. TRENDS Immunol. 2004, 25:590-594.
5. Vergani D., Choudhuri K., Bogdanos D.P., Mieli-Vergani G. Pathogenesis of autoimmune hepatitis. Clin. Liver Dis. 2002, 6:727-737.
6. Czaja A.J., Manns M.P., McFarlane I.G., Hoofnagle J.H. Autoimmune hepatitis: the investigational and clinical challenges. Hepatology 2000, 31:1194-1200.
7. Hashimoto E., Lindor K.D., Homburger H.A., Dickson E.R., Czaja A.J., Wiesner R.H., et al. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clin. Proc. 1993, 68:1049-1055.
8. Balistreri W.F., Chang M.H., Ciocca M., Schwarz K., Porta G., Vegnente A., et al. Acute and chronic hepatitis: Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J. Pediatr. Gastroenterol. Nutr. 2002, 35:S62-S73.
9. Kita H., Mackay I.R., Van De Water J., Gershwin M.E. The lymphoid liver: considerations on pathways to autoimmune injury. Gastroenterology 2001, 120:1485-1501.
10. De Biasio M.B., Periolo N., Avagnina A., García de Dávila M.T., Ciocca M., Goñi J., et al. Liver infiltrating mononuclear cells in children with type 1 autoimmune hepatitis. J. Clin. Pathol. 2006, 59:417-423.
11. Ouyang W., Kolls J.K., Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008, 28:454-467.
12. Sallusto F., Lanzavecchia A. Human Th17 cells in infection and autoimmunity. Microbes Infect. 2009, 5:620-624.
13. Diveu C., McGeachy M.J., Cua D.J. Cytokines that regulate autoimmunity. Curr. Opin. Immunol. 2008, 20:663-668.
14. Singh R., Aggarwal A., Misra R. Th1/Th17 cytokine profiles in patients with reactive arthritis/undifferentiated spondyloarthropathy. J. Rheumatol. 2007, 34:2285-2290.
15. Pene J., Chevalier S., Preisser L., Vénéreau E., Guilleux M.H., Ghannam S., et al. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J. Immunol. 2008, 180:7423-7430.
16. Nistala K., Moncrieffe H., Newton K.R., Varsani H., Hunter P., Wedderburn L.R. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum. 2008, 58:875-887.
17. + suppressor T-cells: more questions than answers. Nat. Rev. Immunol. 2002, 2:389-400.
18. + regulatory T cells. Nat. Immunol. 2003, 4:330-336.
19. + T regulatory cells. Nat. Immunol. 2003, 4:337-342.
20. Li Y., Zhao X., Cheng D., Haga H., Tsuruyama T., Wood K., et al. The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients. Transplantation 2008, 86:1837-1843.
21. Longhi M.S., Ma Y., Bogdanos D.P., Cheeseman P., Mieli-Vergani G., Vergani D. Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease. Hepatology 2004, 41:31-37.
22. + regulatory T cells in health and autoimmune hepatitis. J. Immunol. 2006, 176:4484-4491.
23. + regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis. J. Autoimmun. 2005, 25:63-71.
24. Godfrey D.I., Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 2004, 114:1379-1388.
25. Swain M.G. Hepatic NKT cells: friend or foe?. Clin. Sci. 2008, 114:457-456.
26. + natural killer T cells are related to intrahepatic bile duct lesions in primary biliary cirrhosis. Liver Int. 2003, 23:94-100.
27. Cherñavsky A.C., Paladino N., Rubio A.E., De Biasio M.B., Periolo N., Cuarterolo M., et al. Simultaneous expression of Th1 cytokines and IL-4 confers severe characteristics to type I autoimmune hepatitis in children. Hum. Immunol. 2004, 65:683-691.
28. Takeda K., Hayakawa Y., Van Kaer L., Matsuda H., Yagita H., Okumura K. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc. Natl. Sci. U. S. A. 2000, 97:5498-5503.
29. Knodell R., Ishak K.G., Black W.C., Chen T.S., Craig R., Kaplowitz N., et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981, 1:431-435.
30. Desmet V.J., Gerber M., Hoofnagle J.H., Manns M., Scheuer P.J. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994, 19:1513-1520.
31. Bongers M., Liehl E., Barsig J. One-step RT-PCR to detect cytokine/chemokine induction in macrophages. Focus 2003, 21:66-68.
32. Wesa A., Galy A. Increased production of pro-inflammatory cytokines and enhanced T cell responses after activation of human dendritic cells with IL-1 and CD40 ligand. BMC Immunol. 2002, 3:14.
33. Pflanz S., Timans J.C., Cheung J., Rosales R., Kanzler H., Gilbert J., et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naïve CD4(+) T cells. Immunity 2002, 16:779-790.
34. León A.J., Garrote J.A., Blanco-Quirós A., Calvo C., Fernández-Salazar L., Del Villar A., et al. Interleukin 18 maintains a long-standing inflammation in coeliac disease patients. Clin. Exp. Immunol. 2006, 146:479-485.
35. Karlsson M.G., Ludvigsson J. Determination of mRNA expression for IFNgamma and IL-4 in lymphocytes from children with IDDM by RT-PCR technique. Diabetes Res. Clin. Pract. 1998, 40:21-30.
36. Grose R.H., Thompson F.M., Baxter A.G., Pellicci D.G., Cummins A.G. Deficiency of invariant NK T cells in Crohn's disease and ulcerative colitis. Dig. Dis. Sci. 2007, 52:1415-1422.
37. Roberts T., Beyers N., Aguirre A., Walzl G. Immunosuppression during active tuberculosis is characterized by decreased interferon-gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor-beta, and interleukin-4 mRNA levels. J. Infect. Dis. 2007, 195:870-878.
38. Garcion C., Baltensperger R., Fournier T., Pasquier J., Schnetzer M.A., Gabriel J.P., et al. FiRe and microarrays: a fast answer to burning questions. Trends Plant Sci. 2006, 11:320-322.
39. Godfrey D.I., Hammond K.J., Poulton L.D., Smyth M.J., Baxter A.G. NKT cells: facts, functions and fallacies. Immunol. Today 2002, 21:573-583.
40. Villarino A.V., Huang E., Hunter C.A. Understanding the pro- and anti-inflammatory properties of IL-27. J. Immunol. 2004, 173:715-720.
41. Awasthi A., Carrier Y., Peron J.P., Bettelli E., Kamanaka M., Flavell R.A., et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 2007, 8:1380-1389.
42. Raddatz D., Bockemühl M., Ramadori G. Quantitative measurement of cytokine mRNA in inflammatory bowel disease: relation to clinical and endoscopic activity and outcome. Eur. J. Gastroenterol. Hepatol. 2005, 17:547-557.
43. Reimund J.M., Wittersheim C., Dumont S., Muller C.D., Kenney J.S., Baumann R., et al. Increased production of tumour necrosis factor-alpha, interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut 1996, 39:684-689.
44. Du J., Huang C., Zhou B., Ziegler S.F. Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3. J. Immunol. 2008, 180:4785-4792.
45. Zhou L., Lopes J.E., Chong M.M., Ivanov I.I., Min R., Victora G.D., et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008, 453:236-240.
46. Eastaff-Leung N., Mabarrack N., Barbour A., Cummins A., Barry S. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J. Clin. Immunol. 2010, 30:80-89.
47. Lindley S., Dayan C.M., Bishop A., Roep B.O., Peakman M., Tree T.I. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 2005, 54:92-99.
48. Ehrenstein M.R., Evans J.G., Singh A., Moore S., Warnes G., Isenberg D.A., et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J. Exp. Med. 2004, 200:277-285.
49. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 2004, 199:971-979.
50. + T lymphocytes. J. Immunol. 2007, 178:732-739.
51. Overwijk W.W., Schluns K.S. Functions of gammaC cytokines in immune homeostasis: current and potential clinical applications. Clin. Immunol. 2009, 132:153-165.
52. Murphy T.J., Paterson H.M., Mannick J.A., Lederer J.A. Injury, sepsis, and the regulation of Toll-like receptor responses. J. Leukoc. Biol. 2004, 75:400-407.
53. Suliburk J., Helmer K., Moore F., Mercer D. The gut in systemic inflammatory response syndrome and sepsis. Enzyme systems fighting multiple organ failure. Eur. Surg. Res. 2008, 40:184-189.